Annual FCF:
-$354.66M+$53.41M(+13.09%)Summary
- As of today, NTLA annual free cash flow is -$354.66 million, with the most recent change of +$53.41 million (+13.09%) on December 31, 2024.
- During the last 3 years, NTLA annual free cash flow has fallen by -$116.87 million (-49.15%).
- NTLA annual free cash flow is now -1284.40% below its all-time high of $29.94 million, reached on December 31, 2016.
Performance
NTLA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$76.93M+$22.93M(+22.96%)Summary
- As of today, NTLA quarterly free cash flow is -$76.93 million, with the most recent change of +$22.93 million (+22.96%) on September 30, 2025.
- Over the past year, NTLA quarterly free cash flow has increased by +$9.19 million (+10.67%).
- NTLA quarterly free cash flow is now -215.85% below its all-time high of $66.40 million, reached on June 30, 2016.
Performance
NTLA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$412.63M+$9.19M(+2.18%)Summary
- As of today, NTLA TTM free cash flow is -$412.63 million, with the most recent change of +$9.19 million (+2.18%) on September 30, 2025.
- Over the past year, NTLA TTM free cash flow has dropped by -$49.57 million (-13.65%).
- NTLA TTM free cash flow is now -1001.63% below its all-time high of $45.77 million, reached on June 30, 2016.
Performance
NTLA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NTLA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +13.1% | +10.7% | -13.7% |
| 3Y3 Years | -49.1% | +7.0% | -32.9% |
| 5Y5 Years | -222.3% | -162.9% | -848.6% |
NTLA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -49.1% | +13.1% | -29.9% | +48.6% | -32.9% | +2.2% |
| 5Y | 5-Year | -563.0% | +13.1% | -162.9% | +48.6% | -848.6% | +2.2% |
| All-Time | All-Time | -1284.4% | +13.1% | -215.8% | +48.6% | -1001.6% | +2.2% |
NTLA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$76.93M(+23.0%) | -$412.63M(+2.2%) |
| Jun 2025 | - | -$99.86M(+33.3%) | -$421.82M(-10.7%) |
| Mar 2025 | - | -$149.66M(-73.7%) | -$381.15M(-7.5%) |
| Dec 2024 | -$354.66M(+13.1%) | -$86.18M(-0.1%) | -$354.66M(+2.3%) |
| Sep 2024 | - | -$86.12M(-45.5%) | -$363.06M(+5.1%) |
| Jun 2024 | - | -$59.20M(+51.9%) | -$382.65M(+8.5%) |
| Mar 2024 | - | -$123.17M(-30.2%) | -$418.08M(-2.5%) |
| Dec 2023 | -$408.07M(-17.7%) | -$94.57M(+10.5%) | -$408.07M(-0.2%) |
| Sep 2023 | - | -$105.71M(-11.7%) | -$407.28M(-6.0%) |
| Jun 2023 | - | -$94.62M(+16.4%) | -$384.33M(-1.5%) |
| Mar 2023 | - | -$113.16M(-20.7%) | -$378.77M(-9.2%) |
| Dec 2022 | -$346.85M(-45.9%) | -$93.78M(-13.3%) | -$346.85M(-11.7%) |
| Sep 2022 | - | -$82.76M(+7.1%) | -$310.58M(-4.4%) |
| Jun 2022 | - | -$89.07M(-9.7%) | -$297.38M(-12.5%) |
| Mar 2022 | - | -$81.23M(-41.2%) | -$264.23M(-11.1%) |
| Dec 2021 | -$237.79M(-344.5%) | -$57.52M(+17.3%) | -$237.79M(-7.4%) |
| Sep 2021 | - | -$69.56M(-24.4%) | -$221.50M(-22.2%) |
| Jun 2021 | - | -$55.92M(-2.1%) | -$181.19M(-163.0%) |
| Mar 2021 | - | -$54.79M(-32.9%) | -$68.89M(-28.8%) |
| Dec 2020 | -$53.50M | -$41.23M(-40.9%) | -$53.50M(-23.0%) |
| Sep 2020 | - | -$29.26M(-151.9%) | -$43.50M(-5.0%) |
| Jun 2020 | - | $56.38M(+243.1%) | -$41.44M(+67.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$39.39M(-26.1%) | -$126.44M(-14.9%) |
| Dec 2019 | -$110.03M(-62.7%) | -$31.23M(-14.8%) | -$110.03M(-23.7%) |
| Sep 2019 | - | -$27.20M(+5.0%) | -$88.93M(-16.7%) |
| Jun 2019 | - | -$28.62M(-24.5%) | -$76.20M(-7.4%) |
| Mar 2019 | - | -$22.99M(-126.9%) | -$70.98M(-5.0%) |
| Dec 2018 | -$67.61M(+10.3%) | -$10.13M(+30.0%) | -$67.61M(+16.7%) |
| Sep 2018 | - | -$14.47M(+38.1%) | -$81.19M(+5.5%) |
| Jun 2018 | - | -$23.39M(-19.2%) | -$85.87M(-8.1%) |
| Mar 2018 | - | -$19.62M(+17.2%) | -$79.43M(-5.4%) |
| Dec 2017 | -$75.37M(-351.7%) | -$23.70M(-23.7%) | -$75.37M(-8.5%) |
| Sep 2017 | - | -$19.15M(-13.0%) | -$69.48M(-18.7%) |
| Jun 2017 | - | -$16.95M(-8.9%) | -$58.54M(-335.9%) |
| Mar 2017 | - | -$15.56M(+12.7%) | $24.81M(-17.1%) |
| Dec 2016 | $29.94M(+793.6%) | -$17.82M(-116.9%) | $29.94M(-27.7%) |
| Sep 2016 | - | -$8.21M(-112.4%) | $41.42M(-9.5%) |
| Jun 2016 | - | $66.40M(+736.7%) | $45.77M(+340.2%) |
| Mar 2016 | - | -$10.43M(-64.5%) | -$19.05M(-341.3%) |
| Dec 2015 | -$4.32M(-66.2%) | -$6.34M(-63.9%) | -$4.32M(-313.4%) |
| Sep 2015 | - | -$3.87M(-343.9%) | $2.02M(-65.7%) |
| Jun 2015 | - | $1.59M(-63.2%) | $5.89M(+36.8%) |
| Mar 2015 | - | $4.31M | $4.31M |
| Dec 2014 | -$2.60M | - | - |
FAQ
- What is Intellia Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Intellia Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Intellia Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of NTLA is -$354.66M
What is the all-time high annual free cash flow for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual free cash flow is $29.94M
What is Intellia Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, NTLA annual free cash flow has changed by +$53.41M (+13.09%)
What is Intellia Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of NTLA is -$76.93M
What is the all-time high quarterly free cash flow for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly free cash flow is $66.40M
What is Intellia Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, NTLA quarterly free cash flow has changed by +$9.19M (+10.67%)
What is Intellia Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of NTLA is -$412.63M
What is the all-time high TTM free cash flow for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM free cash flow is $45.77M
What is Intellia Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, NTLA TTM free cash flow has changed by -$49.57M (-13.65%)